Spectramax Light Therapy Shows Promise in Easing Parkinson’s Non-motor Symptoms
PhotoPharmics’s Spectramax light therapy reduces disease severity, lessens non-motor symptoms, and improves the quality of life of Parkinson’s patients,…
Articles by Marta Figueiredo, PhD
Biogen Presents Data on Potential Therapies for Parkinson’s and Progressive Supranuclear Palsy
Biogen has presented data of its research programs evaluating potential treatments for Parkinson’s disease and progressive supranuclear palsy,…
Vitamin D May Improve Balance in Younger Parkinson’s Patients, Pilot Study Suggests
Short-term supplementation of vitamin D in high doses may improve balance in people with Parkinson’s disease younger than 66,…
Specific Tremors, Asthma Meds Not Linked to Parkinson’s Risk, Large Study Suggests
Researchers may have discovered why certain tremors and asthma medications increase the risk of developing Parkinson’s disease. Their findings suggest…
Advantages and Difficulties of Telemedicine in Parkinson’s Analyzed in Review Study
Telemedicine has the potential to become a critical component of healthcare in people with Parkinson’s disease, but larger studies are…
DBS Effectively Reduces Tremor in Parkinson’s Patients, Regardless of Stimulated Brain Area, Study Shows
Deep brain stimulation (DBS) can effectively reduce tremor in people with Parkinson’s disease, regardless of the brain region stimulated, according…
Low-frequency Deep Brain Stimulation Reduces Freezing of Gait, Study Shows
Low-frequency subthalamic deep brain stimulation (STN-DBS), but not high-frequency STN-DBS, reduces freezing of gait in Parkinson’s patients while preserving their…
Communication Deficits in Parkinson’s Patients Caused by Motor and/or Cognitive Impairment
Communication difficulties are caused by motor and/or cognitive impairment in people with Parkinson’s disease, a review study highlights. An interdisciplinary…
Specific Area of Brain Involved in Motor Issues, Slow Thinking in Parkinson’s, Mouse Study Shows
Nerve cell damage in a specific area of the brain impairs motor function and slows thought, both of which are…
Neuropsychiatric Symptoms, Alpha-Synuclein Levels May Help Distinguish Dementia-Related Diseases
Neuropsychiatric symptoms, combined with levels of alpha-synuclein, can be used to distinguish dementia with Lewy bodies from Parkinson’s disease…